Clearance Summary
BioSign Flu A+B received FDA 510(k) clearance under submission number K182157, sponsored by Princeton BioMeditech Corp.. The device was reviewed via the Special premarket notification pathway and assigned to the Microbiology review panel. The statutory decision date of record is 2018-09-18.
- Submission: K182157
- Applicant / Sponsor: Princeton BioMeditech Corp.
- Clearance pathway: Special
- Review panel: Microbiology
- Device class: Class II
- Regulation citation: 21 CFR 866.3328
- Decision date: 2018-09-18
Classification & Regulation
This clearance is catalogued under FDA product code PSZ and 21 CFR 866.3328, within the Microbiology review panel as a Class II device.